Comments on New DNA & Stool-Based Screening Tests to FDA

This week Fight Colorectal Cancer is providing comments to the FDA as they consider two new screening technologies for colorectal cancer. Below are our opinions and recommendations presented to the Molecular and Clinical Genetics Panel as part of the Medical Devices Advisory Committee. Background: This week, the Food & Drug Administration (FDA) is hosting an advisory committee…  Read More

Fight CRC Comments to USPSTF on Draft Research Plan for Screening

[gview file="http://fightcolorectalcancer.org/wordpress/wp-content/uploads/2014/04/FightCRC-Comments-USPSTF-screening-plan.pdf"]